Palvella Therapeutics (PVLA) Assets (2013 - 2026)
Palvella Therapeutics (PVLA) recorded Assets of $253.51 million in Q2 2026, up 243.8% from $73.75 million a year earlier but down 3.9% from the prior quarter.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Palvella Therapeutics reported Assets of $59.56 million, down 32.5% from FY2024.
- Annual Assets has a five-year compound annual growth rate of -10.7% (FY2020 to FY2025).
- Across earlier years, Assets came in at $88.23 million in FY2024, $7.55 million in FY2023 (-92.1%), $95.49 million in FY2022 (-37.8%) and $153.56 million in FY2021 (+46.2%).
- Quarterly Assets has ranged from $7.55 million in Q4 2023 to $263.76 million in Q1 2026 over the past five years.
- On a year-over-year basis, Assets rose in five of the last seven quarters, with growth averaging 138.2%.
- Peak year-over-year performance for Assets in the last five years was growth of 243.8% in Q2 2026, against a decline of 92.1% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $263.76 million (Q1 2026), $59.56 million (Q4 2025) and $66.94 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Palvella Therapeutics | 2.01 Bn | 1.76 Bn | - | 253.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 253.51 Mn |
| Mar 31, 2026 | 263.76 Mn |
| Dec 31, 2025 | 59.56 Mn |
| Sep 30, 2025 | 66.94 Mn |
| Jun 30, 2025 | 73.75 Mn |
| Mar 31, 2025 | 79.44 Mn |
| Dec 31, 2024 | 88.23 Mn |
| Sep 30, 2024 | 20.52 Mn |
| Jun 30, 2024 | 25.05 Mn |
| Mar 31, 2024 | 29.50 Mn |
| Dec 31, 2023 | 7.55 Mn |
| Sep 30, 2023 | 59.38 Mn |
| Jun 30, 2023 | 87.54 Mn |
| Mar 31, 2023 | 82.26 Mn |
| Dec 31, 2022 | 95.49 Mn |
| Sep 30, 2022 | 99.16 Mn |
| Jun 30, 2022 | 114.31 Mn |
| Mar 31, 2022 | 137.12 Mn |
| Dec 31, 2021 | 153.56 Mn |
| Sep 30, 2021 | 164.18 Mn |
API Access
Palvella Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();